Coco (Chengliang) Dong
@DongCoco90417
Followers
60
Following
34
Media
19
Statuses
52
Genetic data scientist at Deerfield Management
Manhattan, NY
Joined December 2016
U.S. FDA approves GlaxoSmithKline's blood cancer drug
cnbc.com
The U.S. Food and Drug Administration on Wednesday approved GlaxoSmithKline's experimental treatment for a common form of blood cancer.
0
0
0
Former prion disease drug candidate anle138b, now being developed for synucleinopathies, has cleared Phase I:
0
5
35
@albertbayes and I created a set of pdf slides with Rmd for all 13 chapters of our book. All pdf and Rmd files are available here: https://t.co/YcBjsUkhIa We hope these will help potential instructors with their course design! Let us know if you have any feedback and thanks!
0
8
24
Congrats to @agbthompson & @smead2 on this exciting @medrxivpreprint: https://t.co/0o0AUGOLfB - incredible patience to assemble 12 years of data on plasma biomarkers in prion disease! Blog post coming soon.
medrxiv.org
Prion diseases are fatal neurodegenerative conditions with highly accurate CSF and imaging diagnostic markers, but major unmet needs for blood biomarkers. Using ultrasensitive immuno-assays, we...
0
7
20
p53 - the ‘guardian of the genome’ - has been extensively pursued as anticancer target. Could immuno-oncology combinations, stapled peptides and targeted degraders unleash its potential? https://t.co/SDagApQ8DQ Find out in this news article by @AsherMullard in the August issue
0
15
24
In a validation data set of 752 biopsy specimens, the rate of agreement with gleason grade defined by subspecialists was significantly higher for a deep learning system than it was for a cohort of general pathologists: https://t.co/kMFX13qXg4
#AI #PCSM
jamanetwork.com
To ascertain whether an assistive tool can improve prostate cancer diagnosis and treatment decisions, this study compares the ability of a deep learning system with those of general pathologists and...
0
1
3
p53 - the guardian of the genome - has long been a compelling but highly challenging anticancer drug target. Find out about the latest progress in the field in this news article by @AsherMullard published today https://t.co/Xb0EQhzDHC
0
14
43
For more on kinases as targets for cancer and other indications, here's a comprehensive review https://t.co/DrU6cQF1vL
0
26
62
Find out more about how gene editing technologies are being used to improve the characteristics of cell therapies in this review from the July issue https://t.co/UP7yUWlO9N
0
8
16
mRNA platforms are at the forefront of efforts to develop vaccines for COVID19 - here's a new article on the intellectual property landscape https://t.co/GBiYvU1dOz and a review on the technology https://t.co/Yg5DHcXTqt
0
15
22
It’s the most wonderful time of the year 🥳🥳🥳 #10ksmallbiz #holidaymarket @ 200 West Street
0
0
0
Is medical school a good investment? Answer this with R
0
0
0
At what point did we stop caring and start accepting that a significant number of Americans don't have access to clean drinking water? https://t.co/P7nouru2j2
0
1
1